Gynecomastia Procedures Market To Reach $1.58 Billion By 2030

Gynecomastia Procedures Market Growth & Trends

The global gynecomastia procedures market size is expected to reach USD 1.58 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 8.8% from 2023 to 2030. The increasing awareness about gynecomastia, changing lifestyles such as sedentary habits, poor diet, hormonal imbalances, and the use of certain medications such as anabolic steroids, and antidepressants are the prime factors that drive the market growth.

Furthermore, advanced minimally invasive procedure approaches such as liposuction and glandular tissue excision have expanded treatment options for gynecomastia. These advancements have improved patient outcomes and satisfaction, further driving market growth. In addition, minimally invasive techniques have gained popularity in gynecomastia treatment as this treatment offers less invasive procedures, reduced scarring, faster recovery times, and improved cosmetic outcomes.

Advanced liposuction techniques, such as power-assisted liposuction (PAL) or ultrasound-assisted liposuction (UAL), have enhanced precision and improved results. Laser-assisted liposuction, such as Smartlipo or VASERlipo, utilizes laser or ultrasound energy to liquefy fat cells before removal. This technique can help tighten the skin and improve overall contour.

COVID-19 had a large impact on the market for gynecomastia. The procedure volume witnessed a significant decrease during the pandemic as gynecomastia is a minimally invasive treatment and the majority of the cosmetic clinics put a halt on such treatments. However, the market regained revenue post-pandemic. During the peak of the pandemic, the healthcare industry drastically adopted a more digital approach to minimize in-person visits and reduce the risk of transmission. This allowed patients to discuss their concerns remotely, including gynecomastia-related issues, and receive guidance or recommendations from healthcare professionals.

 Request a free sample copy or view report summary: Gynecomastia Procedures Market Report

Gynecomastia Procedures Market Report Highlights

• In 2022, North America dominated the market with a 34.5% revenue share. The growth of the market in this region is increasing due to the affordability of healthcare services and the relatively higher disposable incomes of individuals in the region

• Based on age group, the above 40 age group segment dominated with the largest revenue share of 61.0% in 2022.This can be attributed to factors such as hormonal changes, and cumulative effects of risk factors over time are greater in older individuals

• Based on procedure type, the excision segment accounted for the largest revenue share of 54.3% due to its wide indications

• In terms of end-use, cosmetic surgery centers dominate the market with the largest revenue share of 63.8% in 2022, due to their expertise in various aesthetic procedures

Gynecomastia Procedures Market Segmentation

Grand View Research has segmented the global gynecomastia procedures market based on age group, procedure type, end use and region:

Gynecomastia Procedures Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• 18-40

• Above 40

Gynecomastia Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)

• Liposuction

• Excision

Gynecomastia Procedures End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital

• Cosmetic Surgery Center

Gynecomastia Procedures Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Gynecomastia Procedures Market

• Cadila Pharmaceuticals Ltd

• Sun Pharmaceuticals Industries Ltd

• Zydus Cadila Healthcare Ltd

• Biochem Pharmaceutical Industries Ltd

• Dr. Reddy's Laboratories Ltd

• Micro Nova Pharmaceuticals Ltd

• Kee Pharma Ltd